关于安徽六国化工股份有限公司 向特定对象发行股票申请文件的 审核问询函的回复 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 关于安徽六国化工股份有限公司 向特定对象发行股票申请文件的 审核问询函的回复 容诚专字[2025]230Z1756 号 上海证券交易所： 贵所于 2025 年 6 月 10 日出具的《关于安徽六国化工股份有限公司向特定对 象发行股票申请文件的审核问询函》（上证上审（再融资）〔2025〕168 号）已收悉， 容诚会计师事务所(特殊普通合伙)(以下简称"申报会计师")对审核问询函所列问题 进行了逐项落实、核查，现回复如下，请予审核。1 说明： 容诚专字[2025] 230Z1756 号 容诚会计师事务所(特殊普通合伙) 中国·北京 7-2-1 一、除非本回复中另有说明，募集说明书中使用的释义和简称适用于本回复。 ...

补充法律意见书 安徽六国化工股份有限公司 2025 年度向特定对象发行股票 之 安徽天禾律师事务所 ANHUI TIANHE LAW OFFICE 地址：安徽省合肥市怀宁路 288 号置地广场 A 座 34-35F 电话：（0551）62642792 传真：（0551）62620450 安徽天禾律师事务所 六国化工补充法律意见书 安徽天禾律师事务所 关于安徽六国化工股份有限公司 2025 年度向特定对象发行股票之 补充法律意见书 天律意 2025 第 01829 号 致：安徽六国化工股份有限公司 根据《证券法》《公司法》《注册管理办法》等有关法律、法规、规章及规 范性文件的规定，六国化工与本所签订了《聘请专项法律顾问合同》，委托本所 律师以特聘专项法律顾问的身份，参加六国化工本次向特定对象发行股票工作。 本所律师已就六国化工本次发行上市出具了《安徽天禾律师事务所关于安徽 六国化工股份有限公司 2025 年度向特定对象发行股票之法律意见书》（以下简 称"《法律意见书》"）《安徽天禾律师事务所关于安徽六国化工股份有限公司 2025 年度向特定对象发行股票之律师工作报告》（以下简称"《律师工作报告》"）， 现根据上 ...

关于安徽六国化工股份有限公司向特定对象发行 股票申请文件的审核问询函的回复 保荐机构（主承销商） （中国（上海）自由贸易试验区商城路 618 号） 二〇二五年八月 7-1-1 六国化工向特定对象发行股票申请文件 审核问询函的回复 上海证券交易所： 贵所于 2025 年 6 月 10 日出具的《关于安徽六国化工股份有限公司向特定对象 发行股票申请文件的审核问询函》（上证上审（再融资）〔2025〕168 号）已收悉， 安徽六国化工股份有限公司（以下简称"公司""发行人""六国化工"）已会同 国泰海通证券股份有限公司（以下简称"国泰海通证券"或"保荐机构"）及容诚 会计师事务所（特殊普通合伙）（以下简称"申报会计师""会计师"）、安徽天 禾律师事务所（以下简称"律师""发行人律师"）等中介机构对审核问询函的有 关事项进行了认真核查和落实，对申请材料认真地进行了修改、补充和说明。现对 审核问询函逐条书面回复，请予审核。 说明： 一、除非本回复中另有说明，募集说明书中使用的释义和简称适用于本回复。 二、本回复中的字体代表以下含义： | 审核问询函所列问题 | 黑体 | | --- | --- | | 对审核问询函所列问 ...

特此公告。 安徽六国化工股份有限公司董事会 2025 年 8 月 8 日 安徽六国化工股份有限公司（以下简称"公司"或"六国化工"）于 2025 年 6 月 10 日收到上海证券交易所（以下简称"上交所"）出具的《关于安徽六国化工股 份有限公司向特定对象发行股票申请文件的审核问询函》（上证上审（再融资）〔2025〕 168 号）（以下简称"《审核问询函》"），上交所审核机构对公司向特定对象发行 股票申请文件进行了审核，并形成了问询问题。 公司收到《审核问询函》后，按照要求会同相关中介机构就《审核问询函》提 出的问题进行了认真研究和逐项落实，现根据相关要求对《审核问询函》回复进行 公开披露，具体内容详见公司同日在上交所网站（www.see.com.cn）上披露的《关于 安徽六国化工股份有限公司向特定对象发行申请文件的审核问询函的回复》等相关 文件。 公司本次向特定对象发行股票事项尚需通过上交所审核，并获得中国证券监督 管理委员会（以下简称"中国证监会"）作出同意注册的决定后方可实施，最终能 否通过上交所审核，并获得中国证监会同意注册的决定及其时间尚存在不确定性。 公司将根据该事项的进展情况，按照相关法律法规的规 ...

| 代码 | 简称 | 今日涨跌 | 今日换手 | 5日均线 | 10日均线 | 5日较10日均线 | 最新价 | 较10日均线乖 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | （%） | 率（%） | （元） | （元） | 距离（%） | （元） | 离率（%） | | 301137 | 哈焊 | -1.34 | 3.48 | 34.72 | 35.29 | -1.61 | 33.85 | -4.08 | | | 华通 | | | | | | | | | 600468 | 百利 电气 | -1.50 | 1.91 | 6.78 | 6.86 | -1.18 | 6.56 | -4.39 | | 601908 | 京运 | -2.33 | 2.38 | 3.89 | 3.93 | -0.92 | 3.77 | -4.02 | | | 通 | | | | | | | | | 605122 | 四方 | -3.17 | 3.49 | 15.00 | 15.12 | -0.80 | 14.37 | -4.97 | | | 新材 | ...

Core Viewpoint - The petrochemical industry must leverage technological innovation, circular economy, carbon management, and equipment upgrades to become a leader in carbon reduction efforts [1][2]. Group 1: Equipment Upgrades - Equipment upgrades are essential for energy saving and carbon reduction, serving as an "efficiency enhancer" [1]. - Cuohua Group's Huaxing Chemical implemented variable frequency transformations on sulfuric acid plant pumps and SO2 fans, saving 1.7145 million kWh of electricity and 1.2 million yuan in electricity costs annually [1]. - Cuohua Liuguo Chemical upgraded air compressors to permanent magnet variable frequency models, reducing ineffective operation and saving 170,000 kWh of electricity annually, equivalent to 20.89 tons of standard coal [1]. - Cuohua Organic Chemical customized high-efficiency pumps using multi-condition hydraulic optimization technology, saving 117,000 kWh of electricity and reducing CO2 emissions by 96.5 tons annually [1]. Group 2: Intelligent Management - Intelligent management acts as an "accelerator" for energy saving and carbon reduction [2]. - Huaxing Chemical implemented a "dual-engine" management system to dynamically monitor 87 key energy consumption indicators, ensuring timely optimization of energy-saving measures [2]. - Liuguo Chemical utilized pressure recovery technology to achieve 3.2 million kWh of annual electricity generation from recycled water [2]. - Cuohua Group's New Bridge Mining Company established an intelligent pump room for unattended operation, saving 200,000 kWh of electricity annually [2]. Group 3: Green Energy Alternatives - Transitioning from fossil fuels to renewable energy is an effective pathway to achieve carbon neutrality [2]. - Cuohua Group actively applies technologies such as cogeneration, clean coal gasification, and waste heat power generation to enhance energy utilization efficiency [2]. - The company is exploring joint ventures for photovoltaic power generation projects to increase green electricity usage and has developed a clear roadmap for green electricity replacement [2]. - Cuohua Group prioritizes the deployment of photovoltaic power on factory rooftops and idle land, while also exploring low-carbon energy applications like green hydrogen and biomass energy [2]. Group 4: Overall Impact - The practice demonstrates that green transformation is not merely a cost burden for companies but a core source of competitive advantage [2]. - Embedding energy saving and carbon reduction into the development foundation is crucial for leading the industry in carbon reduction efforts, ultimately achieving a win-win situation for economic and ecological benefits [2].

Group 1 - The company expects a net profit attributable to shareholders of the parent company for the first half of 2025 to be between -140 million and -170 million yuan, indicating a loss compared to the same period last year [1][2] - The expected net profit after deducting non-recurring gains and losses for the first half of 2025 is also projected to be between -140 million and -170 million yuan [1][2] Group 2 - The main reasons for the anticipated loss include a decline in sales prices of key products like urea due to macroeconomic conditions and government policies affecting the fertilizer industry, as well as a significant decrease in export volumes [2] - The report period saw a continuous rise in international sulfur prices, leading to increased procurement costs for domestic sulfur and sulfuric acid, as well as a notable rise in potassium fertilizer prices, which contributed to higher costs for phosphate fertilizer products [2] - There was an increase in the provision for various impairment losses compared to the previous year [2]

[Anhui Liuguo Chemical Co., Ltd. 2025 Semi-Annual Performance Pre-Loss Announcement](index=1&type=section&id=Anhui%20Liuguo%20Chemical%20Co.%2C%20Ltd.%202025%20Semi-Annual%20Performance%20Pre-Loss%20Announcement) [Current Period Performance Forecast](index=1&type=section&id=I.%20Current%20Period%20Performance%20Forecast) The company forecasts an unaudited net loss for H1 2025, with attributable net profit between -RMB 140 million and -RMB 170 million, reversing prior year's profit 2025 H1 Estimated Performance | Performance Indicator | 2025 H1 Estimate | | :--- | :--- | | Net Profit Attributable to Parent Company Owners | -RMB 140 million to -RMB 170 million | | Net Profit Attributable to Parent Company Owners (Excluding Non-recurring Items) | -RMB 140 million to -RMB 170 million | - These performance forecast figures are **unaudited** by a certified public accountant[4](index=4&type=chunk) [Prior Period Performance Comparison](index=1&type=section&id=II.%20Prior%20Period%20Operating%20Performance%20and%20Financial%20Condition) In H1 2024, the company achieved profitability, reporting attributable net profit of RMB 29.37 million and EPS of RMB 0.06, contrasting the current period's forecast loss 2024 H1 Performance | Performance Indicator | 2024 H1 | | :--- | :--- | | Net Profit Attributable to Parent Company Owners | RMB 29.37 million | | Net Profit Attributable to Parent Company Owners (Excluding Non-recurring Items) | RMB 10.08 million | | Earnings Per Share | RMB 0.06 | [Analysis of Performance Pre-Loss Reasons](index=2&type=section&id=III.%20Main%20Reasons%20for%20Current%20Period%20Performance%20Pre-Loss) The company's projected loss is attributed to declining product prices and export volumes, rising raw material costs for phosphorus fertilizers, and increased impairment provisions - Revenue pressure stems from declining sales prices and significantly reduced export volumes for key products like urea, influenced by macroeconomic conditions and national price stabilization and export control policies[7](index=7&type=chunk) - Cost increases are driven by a substantial year-over-year rise in international sulfur prices, impacting domestic sulfur and sulfuric acid procurement, alongside significant increases in potash fertilizer purchase prices, collectively elevating phosphorus fertilizer production costs[7](index=7&type=chunk) - Increased impairment provisions during the reporting period have further impacted current period profit[7](index=7&type=chunk) [Risk Warning](index=2&type=section&id=IV.%20Risk%20Warning) This performance forecast is a preliminary, unaudited estimate based on current operations, with no material uncertainties affecting its accuracy - This performance forecast represents the company's preliminary estimate based on operating conditions and has not been audited by an accounting firm[8](index=8&type=chunk) [Other Explanations](index=2&type=section&id=V.%20Other%20Explanations) The company advises investors that disclosed figures are preliminary; final accurate financial data will be based on the official 2025 semi-annual report, urging caution regarding investment risks - The final accurate financial data will be subject to the company's officially disclosed 2025 semi-annual report, and investors are advised to exercise caution regarding investment risks[9](index=9&type=chunk)

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

股票简称：六国化工 股票代码：600470 公告编号：2025-041 安徽六国化工股份有限公司董事会 2025年7月2日 梁晨先生任职期间恪尽职守，勤勉尽责，公司董事会对梁晨先生任职期间 为公司发展做出的贡献表示衷心感谢！ 特此公告。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 安徽六国化工股份有限公司（以下简称"公司"）董事会近日收到副总经 理梁晨先生的书面辞职报告，梁晨先生因工作变动，辞去公司副总经理职务。 根据《公司法》和《公司章程》的有关规定，梁晨先生的辞职报告自送达公司 董事会时生效。辞职后，不再担任公司及子公司任何职务，截至本公告披露 日，梁晨先生未持有公司股票。 ...